Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed1
Recruiting1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04474847Phase 3Recruiting
Abatacept for the Treatment of Giant Cell Arteritis
Giant Cell Arteritis
PrincipalinvestigatorStart date: 2021-03-29
NCT02108860Phase 3Completed
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
ANCA-Associated VasculitisGranulomatosis With PolyangiitisGranulomatosis With Polyangiitis (Wegener's)+1 more
PrincipalinvestigatorStart date: 2015-04-25

Research Network

Collaboration Network

8 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey P Krischer, PhD

University of South Florida

Moderately Similar
3 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGiant Cell Arteritis+1 more

Worked with same sponsors:

Bristol-Myers SquibbNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)+4 more
Collaborated on 2 trials
Similarity Score48%

Peter A Merkel, MD, MPH

University of Pennsylvania

Moderately Similar
10 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisGiant Cell ArteritisAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis+1 more

Worked with same sponsors:

Bristol-Myers SquibbNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)+4 more
Collaborated on 2 trials
Similarity Score48%

Peter Merkel, MD, MPH

University of Pennsylvania

Related
4 trials

Shared therapeutic areas:

Giant Cell ArteritisGranulomatosis With Polyangiitis (Wegener's)Granulomatosis with Polyangiitis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)University of Pennsylvania
Similarity Score23%

Ulrich Specks, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score15%

Amanda M. Terry, MA

University of South Florida College of Medicine

Related
2 trials

Shared therapeutic areas:

Giant Cell ArteritisGranulomatosis with Polyangiitis

Worked with same sponsors:

University of PennsylvaniaUniversity of South Florida
Similarity Score15%

Peter A. Merkel, MD, MPH

Boston University

Related
2 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisGiant Cell Arteritis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)University of Pennsylvania+1 more
Similarity Score15%

Peter C. Grayson, MD

Boston University

Related
2 trials

Shared therapeutic areas:

Giant Cell ArteritisGranulomatosis with Polyangiitis

Worked with same sponsors:

University of PennsylvaniaUniversity of South Florida
Similarity Score15%

Juhong Shi, M.D

Peking Union Medical College Hospital

Related
8 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGranulomatosis with Polyangiitis
Similarity Score15%

Peter A. Merkel, MD, MPH

University of Pennsylvania

Related
10 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisGiant Cell Arteritis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)University of Pennsylvania+1 more
Similarity Score15%

Lindi Jiang, PhD

Fudan University

Related
7 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGranulomatosis with Polyangiitis
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04474847Phase 3PrincipalInvestigator

Abatacept for the Treatment of Giant Cell Arteritis

Giant Cell Arteritis
Recruiting
NCT02108860Phase 3PrincipalInvestigator

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

ANCA-Associated VasculitisGranulomatosis With PolyangiitisGranulomatosis With Polyangiitis (Wegener's)+1 more
Completed

All 2 trials loaded